The One Big Beautiful Bill Act may offer some positives for health care in general and rheumatology specifically, according to Christina Downey, MD, chair of the American College of Rheumatology ...

In this video, Erica L. Mayer, MD, MPH, discusses the SERENA-6 study, which assessed the efficacy of switching to camizestrant plus a CDK 4/6 inhibitor vs. continuing standard treatment among patients ...